VWWMG
LEGN icon

Vermillion & White Wealth Management Group’s Legend Biotech LEGN Stock Holding History

Vermillion & White Wealth Management Group’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-25
Closed -$543 – 319
2025
Q4 		$543 Hold
25
– – ﹤0.01% 552
2025
Q3 		$815 Hold
25
– – ﹤0.01% 535
2025
Q2 		$887 Hold
25
– – ﹤0.01% 497
2025
Q1 		$848 Hold
25
– – ﹤0.01% 484
2024
Q4 		$814 Buy
+25
New +$1.04K ﹤0.01% 346
2024
Q3 		– Sell
-25
Closed -$1.11K – 367
2024
Q2 		$1.11K Hold
25
– – ﹤0.01% 327
2024
Q1 		$1.4K Hold
25
– – ﹤0.01% 299
2023
Q4 		$1.5K Buy
+25
New +$1.58K ﹤0.01% 257

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
FBIL
First Beijing Investment Ltd Hong Kong $2.32B AUM 8.06% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Vermillion & White Wealth Management Group's LEGN Position: Q1 2026 in Review

Vermillion & White Wealth Management Group sold out of Legend Biotech (LEGN) in Q1 2026, closing a stake of 25 shares — an estimated $543 sold.

Vermillion & White Wealth Management Group first reported a position in LEGN in Q4 2023 and held it in 8 quarters. The position peaked at $1.5K in Q4 2023. 189 funds tracked by Wall St. Rank hold LEGN as of Q1 2026.

  • Vermillion & White Wealth Management Group reported no remaining Legend Biotech position as of Q1 2026 after selling out during the quarter.
  • Vermillion & White Wealth Management Group sold 25 Legend Biotech shares in Q1 2026, an estimated $543.
  • Vermillion & White Wealth Management Group first reported a position in Legend Biotech in Q4 2023 and held it in 8 quarters.
  • Vermillion & White Wealth Management Group's Legend Biotech position peaked at $1.5K in Q4 2023.
  • 189 funds tracked by Wall St. Rank held Legend Biotech as of Q1 2026.

Based on Vermillion & White Wealth Management Group's 13F filing for Q1 2026, filed 14 May 2026.